UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

I can’t believe this is happening." A Texas surgeon was performing surgery when she received an unexpected call from the ...

UnitedHealth Q4 earnings beat EPS estimates at $6.81 but missed revenue projections. Analysts highlight growth potential in ...

Healthcare fraud investigations accounted for more than half of the Department of Justice's settlements and judgments in 2024 ...

As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...

KeyBanc Capital Markets reiterated its Overweight rating on UnitedHealth Group shares (NYSE:UNH), maintaining a price target ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Analyst Joanna Gajuk of Bank of America Securities maintained a Buy rating on UnitedHealth (UNH – Research Report), reducing the price target ...